Patents by Inventor Ashish Sudhakar Paradkar

Ashish Sudhakar Paradkar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Isolated DNA comprising one or more genes specific for 5S clavam biosynthesis, vectors comprising such DNA and hosts capable of improved clavulanic acid production
    Patent number: 7344869
    Abstract: Novel bacterial genes, microorganisms and processes for improving the manufacture of 5R clavams, eg. clavulanic acid.
    Type: Grant
    Filed: October 8, 2004
    Date of Patent: March 18, 2008
    Assignees: SmithKline Beecham p.l.c., The Governors of the University of Alberta
    Inventors: Cecilia Anders, Barry Barton, John Patrick Griffin, Susan Jensen, Roy Henry Mosher, Ashish Sudhakar Paradkar
  • Isolated DNA comprising one or more genes specific for 5S clavam biosynthesis, vectors comprising such DNA and streptomyces hosts capable of improved clavulanic acid production
    Patent number: 6936458
    Abstract: Novel bacterial genes, microorganisms and processes for improving the manufacture of 5R clavams, eg. clavulanic acid.
    Type: Grant
    Filed: July 9, 1999
    Date of Patent: August 30, 2005
    Assignees: SmithKline Beecham p.l.c., The Governors of the University of Alberta
    Inventors: Cecilia Anders, Barry Barton, John Patrick Griffin, Susan Jensen, Roy Henry Mosher, Ashish Sudhakar Paradkar
  • Novel process
    Publication number: 20040081960
    Abstract: Novel bacterial genes, microorganisms and processes for improving the manufacture of 5R clavams, eg. clavulanic acid.
    Type: Application
    Filed: February 24, 2003
    Publication date: April 29, 2004
    Applicants: SmithKline Beecham p.l.c., The Governors of the University of Alberta
    Inventors: Cecilia Anders, Barry Barton, John Patrick Griffin, Susan Jensen, Roy Henry Mosher, Ashish Sudhakar Paradkar
  • Process for clavulanic acid production
    Publication number: 20030166175
    Abstract: Novel bacterial genes, microorganisms and processes for improving the manufacture of 5R clavams, eg. clavulanic acid.
    Type: Application
    Filed: November 7, 2002
    Publication date: September 4, 2003
    Applicant: SmithKline Beecham plc
    Inventors: Cecilia Anders, Barry Barton, John Patrick Griffin, Susan Jensen, Roy Henrey Mosher, Ashish Sudhakar Paradkar
  • Novel compounds
    Publication number: 20030124690
    Abstract: Novel bacterial genes, microorganisms and processes for improving the manufacture of 5R clavams, eg. clavulanic acid.
    Type: Application
    Filed: November 7, 2002
    Publication date: July 3, 2003
    Applicant: SmithKline Beecham plc
    Inventors: Cecilia Anders, Barry Barton, John Patrick Griffin, Susan Jensen, Roy Henry Mosher, Ashish Sudhakar Paradkar
  • Novel process
    Publication number: 20030109694
    Abstract: Novel bacterial genes, microorganisms and processes for improving the manufacture of 5R clavams, eg. clavulanic acid.
    Type: Application
    Filed: November 6, 2002
    Publication date: June 12, 2003
    Applicant: SmithKline Beecham plc
    Inventors: Cecilia Anders, Barry Barton, John Patrick Griffin, Susan Jensen, Roy Henry Mosher, Ashish Sudhakar Paradkar
  • Novel compounds
    Publication number: 20030022321
    Abstract: Novel bacterial genes, microorganisms and processes for improving the manufacture of 5R clavams, eg. clavulanic acid.
    Type: Application
    Filed: February 8, 2002
    Publication date: January 30, 2003
    Applicant: SmithKline Beecham p.l.c.
    Inventors: Cecilia Anders, Barry Barton, John Patrick Griffin, Susan Jensen, Roy Henrey Mosher, Ashish Sudhakar Paradkar
  • Process to increase the production of clavam antibiotics
    Patent number: 6171814
    Abstract: A process for increasing the amount of clavam produced by an organism having both a clavam pathway or a portion thereof and a cephalosporin pathway or a portion thereof by interfering with the conversion of L-lysine to L-&agr;-aminoadipic acid in the cephalosporin pathway. Plasmids containing a defective LAT (lysine amino transferase) gene and organisms containing such plasmids are also provided.
    Type: Grant
    Filed: May 11, 1998
    Date of Patent: January 9, 2001
    Assignees: SmithKline Beecham p.l.c., The Governors of the University of Alberta
    Inventors: William Henry Holms, Ashish Sudhakar Paradkar, Roy Henry Mosher